A Phase 1, Randomized Hyperinsulinemic Euglycemic Clamp Study to Assess Insulin Sensitivity and other Metabolic Parameters after Single Dose of Azelaprag in Obese Participants
-
Enrollment
This study is not currently enrolling. -
Research Area
Translational Research -
Sponsor
BioAge Labs